Published by EMA on 05-May-2014

In March 2014, the Agency began publishing summaries of RMPs for centrally authorised medicines.

These are intended to allow stakeholders wider access to the information behind the decision-making process of European regulatory authorities when they review the safety of a medicine or active substance.

For further information on RMP summaries and their role, see: